Longview News-Journal1mon
Enzyme-Linked Immunosorbent Assay (ELISA) Market to Grow by USD 843.9 Million (2024-2028) as AI Drives Demand for Frequent Diagnostic Testing
NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global enzyme-linked immunosorbent assay (elisa) market size is estimated to grow by USD 843.9 ...
Yahoo Finance1d
Leading Global IHC Service: Boster Biological Technology Changes the Game with World-Class, Cost-Effective Antibody Solutions
Widely acclaimed for its immunohistochemistry services, Boster Biological Technology emerges as one of the largest and most ...
Nature2y
AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery
They exhibit remarkable sensitivity, wide dynamic range and robust performance that compares advantageously with conventional enzyme-linked immunosorbent assay (ELISA). ELISA is the most widely ...
Business Insider3d
Medigene Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024
The presented poster displayed a direct comparison between the conventional standard method Enzyme-linked Immunosorbent Assay (ELISA) and the Company´s proprietary innovative IFN-γ Biosensor to ...
precisionmedicineonline3d
Nordic Bioscience Gets FDA Letter of Support for CPa9-HNE Biomarker in IBD
The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.